Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | 17-AAG | 0.1 | uM | 10 | 1250.00 | 353.09 | 361.00 | 1170.50 | 0.3084 | 0.0129 |
| MCF7 | Erlotinib | 0.031623 | uM | 10 | 1250.00 | 353.09 | 1482.00 | 1170.50 | 1.2661 | 1.2924 |
| MCF7 | Erlotinib | 1 | uM | 10 | 1250.00 | 353.09 | 1261.00 | 1170.50 | 1.0773 | 1.0880 |
| MCF7 | Linsitinib | 0.31623 | uM | 10 | 1250.00 | 353.09 | 1173.00 | 1170.50 | 1.0021 | 1.0025 |
| MCF7 | Lapatinib | 3.1623 | uM | 10 | 1250.00 | 353.09 | 1108.00 | 1170.50 | 0.9466 | 0.9375 |
| MCF7 | 17-AAG | 0.031623 | uM | 10 | 1250.00 | 353.09 | 481.00 | 1170.50 | 0.4109 | 0.1958 |
| MCF7 | Erlotinib | 0.1 | uM | 10 | 1250.00 | 353.09 | 1359.00 | 1170.50 | 1.1610 | 1.1804 |
| MCF7 | 0 | uM | 10 | 1250.00 | 353.09 | 1526.00 | 1170.50 | 1.3037 | 1.3316 | |
| MCF7 | Linsitinib | 0.1 | uM | 10 | 1250.00 | 353.09 | 1160.00 | 1170.50 | 0.9910 | 0.9896 |
| MCF7 | Lapatinib | 0.0016596 | uM | 10 | 1250.00 | 353.09 | 1415.00 | 1170.50 | 1.2089 | 1.2319 |
| MCF7 | Lapatinib | 0.0033113 | uM | 10 | 1250.00 | 353.09 | 1204.00 | 1170.50 | 1.0286 | 1.0329 |
| MCF7 | Linsitinib | 1 | uM | 10 | 1250.00 | 353.09 | 778.00 | 1170.50 | 0.6647 | 0.5792 |
| MCF7 | Lapatinib | 0.01 | uM | 10 | 1250.00 | 353.09 | 1197.00 | 1170.50 | 1.0226 | 1.0261 |
| MCF7 | Linsitinib | 0.031623 | uM | 10 | 1250.00 | 353.09 | 1281.00 | 1170.50 | 1.0944 | 1.1071 |
| MCF7 | 17-AAG | 1 | uM | 10 | 1250.00 | 353.09 | 389.00 | 1170.50 | 0.3323 | 0.0576 |
| MCF7 | 0 | uM | 10 | 1250.00 | 353.09 | 1361.00 | 1170.50 | 1.1628 | 1.1823 | |
| MCF7 | Lapatinib | 0.1 | uM | 10 | 1250.00 | 353.09 | 909.00 | 1170.50 | 0.7766 | 0.7279 |
| MCF7 | Lapatinib | 0.031623 | uM | 10 | 1250.00 | 353.09 | 981.00 | 1170.50 | 0.8381 | 0.8058 |
| MCF7 | 0 | uM | 10 | 1250.00 | 353.09 | 1172.00 | 1170.50 | 1.0013 | 1.0015 | |
| MCF7 | 0 | uM | 10 | 2500.00 | 703.32 | 2373.00 | 2610.50 | 0.9090 | 0.9017 | |
| MCF7 | 17-AAG | 3.1623 | uM | 10 | 2500.00 | 703.32 | 646.00 | 2610.50 | 0.2475 | -0.0439 |
| MCF7 | Erlotinib | 0.01 | uM | 10 | 2500.00 | 703.32 | 2558.00 | 2610.50 | 0.9799 | 0.9786 |
| MCF7 | Linsitinib | 3.1623 | uM | 10 | 2500.00 | 703.32 | 1270.00 | 2610.50 | 0.4865 | 0.3666 |
| MCF7 | Erlotinib | 0.0033113 | uM | 10 | 2500.00 | 703.32 | 2779.00 | 2610.50 | 1.0645 | 1.0672 |
| MCF7 | Lapatinib | 10 | uM | 10 | 2500.00 | 703.32 | 1043.00 | 2610.50 | 0.3995 | 0.2315 |